SHARE
COPY LINK

COVID-19

Europe’s ‘alarming’ infection rates and shorter quarantine periods worry WHO chiefs

The European chapter of the World Health Organization on Thursday said it saw "alarming rates of transmission" of Covid-19 across the region and warned countries against shortening quarantine periods.

Europe's 'alarming' infection rates and shorter quarantine periods worry WHO chiefs
A Spanish health worker and volunteer of the SAMU Foundation forms the figure of a heart with her hands before entering the intensive care unit. AFP

The WHO's regional director for Europe Hans Kluge said the number of coronavirus cases seen in September “should serve as a wake-up call for all of us.”

“Although these numbers reflect more comprehensive testing, it also shows alarming rates of transmission across the region,” he told an online press conference from Danish capital Copenhagen.

The health body also said it would not change its guidance calling for a 14-day quarantine period for anyone exposed to the novel coronavirus.

“Our quarantine recommendation of 14 days has been based on our understanding of the incubation period and transmission of the disease. We would only revise that on the basis of a change of our understanding of the science,” WHO Europe's senior emergency officer Catherine Smallwood said.

In France for instance, the recommended length for self-isolation in case of exposure has been reduced to seven days.

It is 10 days in the UK and Ireland, and several more European countries, such as Portugal and Croatia, are currently considering reducing their recommendations.

“Knowing the immense individual and societal impact even a slight reduction in the length of quarantine can have… I encourage countries of the region to make scientific due process with their experts and explore safe reduction options,” Kluge said, adding that the “concept of quarantine must be protected” and “continuously adapted.”

The 53 member states of WHO Europe have recorded nearly five million cases of Covid-19 and more than 227,000 related deaths, according to the organisation's own figures.

The number of daily cases recorded is currently between 40,000 and 50,000, comparable to a daily peak of 43,000 on April 1 — although testing in many countries has increased considerably.

A new record was set on September 11, with some 54,000 cases recorded in 24  hours.

Member comments

Log in here to leave a comment.
Become a Member to leave a comment.

COVID-19

Medical row in France over unauthorised Covid trial

French medical bodies on Sunday called on authorities to punish researcher Didier Raoult for "the largest 'unauthorised' clinical trial ever seen" into the use of hydroxychloroquine to treat Covid-19.

Medical row in France over unauthorised Covid trial

French medical bodies on Sunday called on authorities to punish researcher Didier Raoult for “the largest ‘unauthorised’ clinical trial ever seen” into the use of hydroxychloroquine to treat Covid-19.

Raoult, the former head of the IHU Mediterranee research hospital, and his subordinates engaged in “systematic prescription of medications as varied as hydroxychloroquine, zinc, ivermectin and azithromycin to patients suffering from Covid-19… without a solid pharmacological basis and lacking any proof of their effectiveness,” a group of 16 research bodies wrote in an op-ed piece  on daily Le Monde’s website.

The drugs continued to be prescribed “for more than a year after their ineffectiveness had been absolutely demonstrated,” they added.

Endorsement from respected tropical disease specialist Raoult helped push anti-malaria drug hydroxychloroquine into the public consciousness in the early days of the coronavirus pandemic, feeding into its promotion by former US President Donald Trump and Brazil’s then-leader Jair Bolosonaro.

In April, France’s ANSM medications authority said that treatment with hydroxichloroquine “exposes patients to potential side effects that can be serious”.

The doctors’ bodies said Sunday that authorities should take “measures appropriate to the infractions” for the sake of patient safety and “the credibility of French medical research”.

Raoult in March published a “pre-print” study — not yet submitted for scientific peer review — into treatment of more than 30,000 Covid-19 patients.

So far no one has been charged in a probe opened last year by Marseille prosecutors into fraud and unwarranted human testing at the IHU Mediterranee, based in the southern port city.

The government has also requested an investigation into the IHU’s conduct under Raoult’s management following a harsh report from inspectors.

Health Minister Francois Braun told broadcaster RTL on Sunday that he would not comment on an open investigation, but confirmed that the latest study would be included in the probe’s remit.

Raoult retired as a professor in summer 2021 and was replaced at the IHU Mediterrannee last August.

A spokesman said he remained an emeritus professor and was still supervising two doctoral students who began work on their theses before he left.

At the IHU itself, all clinical trials involving humans have been suspended since Raoult’s replacement Pierre-Edouard Fournier took over.

The hospital told AFP it was waiting for the ANSM drug regulator’s word before resuming the trials.

“The IHU has to show it has met expectations” before human testing would be allowed, the ANSM said, without setting out a timeframe.

SHOW COMMENTS